174 related articles for article (PubMed ID: 31235660)
21. Seizures and Encephalitis in Myelin Oligodendrocyte Glycoprotein IgG Disease vs Aquaporin 4 IgG Disease.
Hamid SHM; Whittam D; Saviour M; Alorainy A; Mutch K; Linaker S; Solomon T; Bhojak M; Woodhall M; Waters P; Appleton R; Duddy M; Jacob A
JAMA Neurol; 2018 Jan; 75(1):65-71. PubMed ID: 29131884
[TBL] [Abstract][Full Text] [Related]
22. Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodies.
Maillart E; Durand-Dubief F; Louapre C; Audoin B; Bourre B; Derache N; Ciron J; Collongues N; de Sèze J; Cohen M; Lebrun-Frenay C; Hadhoum N; Zéphir H; Deschamps R; Carra-Dallière C; Labauge P; Kerschen P; Montcuquet A; Wiertlewski S; Laplaud D; Runavot G; Vukusic S; Papeix C; Marignier R;
J Neuroinflammation; 2020 Apr; 17(1):128. PubMed ID: 32326965
[TBL] [Abstract][Full Text] [Related]
23. Idiopathic aquaporin-4 antibody negative longitudinally extensive transverse myelitis.
Hyun JW; Kim SH; Huh SY; Kim W; Yun J; Joung A; Sato DK; Fujihara K; Kim HJ
Mult Scler; 2015 May; 21(6):710-7. PubMed ID: 25305252
[TBL] [Abstract][Full Text] [Related]
24. Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease.
Lechner C; Baumann M; Hennes EM; Schanda K; Marquard K; Karenfort M; Leiz S; Pohl D; Venkateswaran S; Pritsch M; Koch J; Schimmel M; Häusler M; Klein A; Blaschek A; Thiels C; Lücke T; Gruber-Sedlmayr U; Kornek B; Hahn A; Leypoldt F; Sandrieser T; Gallwitz H; Stoffels J; Korenke C; Reindl M; Rostásy K
J Neurol Neurosurg Psychiatry; 2016 Aug; 87(8):897-905. PubMed ID: 26645082
[TBL] [Abstract][Full Text] [Related]
25. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.
Jarius S; Kleiter I; Ruprecht K; Asgari N; Pitarokoili K; Borisow N; Hümmert MW; Trebst C; Pache F; Winkelmann A; Beume LA; Ringelstein M; Stich O; Aktas O; Korporal-Kuhnke M; Schwarz A; Lukas C; Haas J; Fechner K; Buttmann M; Bellmann-Strobl J; Zimmermann H; Brandt AU; Franciotta D; Schanda K; Paul F; Reindl M; Wildemann B;
J Neuroinflammation; 2016 Nov; 13(1):281. PubMed ID: 27802825
[TBL] [Abstract][Full Text] [Related]
26. Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature.
Nagireddy RBR; Kumar A; Singh VK; Prasad R; Pathak A; Chaurasia RN; Mishra VN; Joshi D
J Neuroimmunol; 2021 Dec; 361():577742. PubMed ID: 34655992
[TBL] [Abstract][Full Text] [Related]
27. Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders.
López-Chiriboga AS; Majed M; Fryer J; Dubey D; McKeon A; Flanagan EP; Jitprapaikulsan J; Kothapalli N; Tillema JM; Chen J; Weinshenker B; Wingerchuk D; Sagen J; Gadoth A; Lennon VA; Keegan BM; Lucchinetti C; Pittock SJ
JAMA Neurol; 2018 Nov; 75(11):1355-1363. PubMed ID: 30014148
[TBL] [Abstract][Full Text] [Related]
28. Changes of retinal structure and visual function in patients with demyelinating transverse myelitis.
Lee JH; Moon Y; Kwon YN; Shin JH; Kim SM; Jung JH
Neurol Sci; 2022 Nov; 43(11):6425-6431. PubMed ID: 35939134
[TBL] [Abstract][Full Text] [Related]
29. Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases.
Hyun JW; Woodhall MR; Kim SH; Jeong IH; Kong B; Kim G; Kim Y; Park MS; Irani SR; Waters P; Kim HJ
J Neurol Neurosurg Psychiatry; 2017 Oct; 88(10):811-817. PubMed ID: 28684532
[TBL] [Abstract][Full Text] [Related]
30. What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive? A cross sectional study of 132 patients.
Hamid SHM; Whittam D; Mutch K; Linaker S; Solomon T; Das K; Bhojak M; Jacob A
J Neurol; 2017 Oct; 264(10):2088-2094. PubMed ID: 28840314
[TBL] [Abstract][Full Text] [Related]
31. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica.
Rostásy K; Mader S; Hennes EM; Schanda K; Gredler V; Guenther A; Blaschek A; Korenke C; Pritsch M; Pohl D; Maier O; Kuchukhidze G; Brunner-Krainz M; Berger T; Reindl M
Mult Scler; 2013 Jul; 19(8):1052-9. PubMed ID: 23257621
[TBL] [Abstract][Full Text] [Related]
32. Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease.
Höftberger R; Sepulveda M; Armangue T; Blanco Y; Rostásy K; Calvo AC; Olascoaga J; Ramió-Torrentà L; Reindl M; Benito-León J; Casanova B; Arrambide G; Sabater L; Graus F; Dalmau J; Saiz A
Mult Scler; 2015 Jun; 21(7):866-874. PubMed ID: 25344373
[TBL] [Abstract][Full Text] [Related]
33. Serum Neurofilament to Magnetic Resonance Imaging Lesion Area Ratio Differentiates Spinal Cord Infarction From Acute Myelitis.
Sechi E; Mariotto S; McKeon A; Krecke KN; Pittock SJ; Ferrari S; Monaco S; Flanagan EP; Zanzoni S; Rabinstein AA; Wingerchuk DM; Nasr DM; Zalewski NL
Stroke; 2021 Jan; 52(2):645-654. PubMed ID: 33423516
[TBL] [Abstract][Full Text] [Related]
34. Etiologies of acute demyelinating optic neuritis: an observational study of 110 patients.
Deschamps R; Lecler A; Lamirel C; Aboab J; Gueguen A; Bensa C; Vignal C; Gout O
Eur J Neurol; 2017 Jun; 24(6):875-879. PubMed ID: 28477397
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates.
Sepúlveda M; Aldea M; Escudero D; Llufriu S; Arrambide G; Otero-Romero S; Sastre-Garriga J; Romero-Pinel L; Martínez-Yélamos S; Sola-Valls N; Armangué T; Sotoca J; Escartín A; Robles-Cedeño R; Ramió-Torrentà L; Presas-Rodríguez S; Ramo-Tello C; Munteis E; Pelayo R; Gubieras L; Brieva L; Ortiz N; Hervás M; Mañé-Martínez MA; Cano A; Vela E; Tintoré M; Blanco Y; Montalban X; Graus F; Saiz A
Mult Scler; 2018 Dec; 24(14):1843-1851. PubMed ID: 28984163
[TBL] [Abstract][Full Text] [Related]
36. [Analysis of magnetic resonance imaging characteristics in Chinese patients with myelin oligodendrocyte glycoprotein antibody associated disorders].
Liu CX; Chen C; Zhong XN; Wang YG; Yang Y; Li R; Sun XB; Fang L; Peng LS; Qiu W
Zhonghua Yi Xue Za Zhi; 2020 Feb; 100(5):328-333. PubMed ID: 32074774
[No Abstract] [Full Text] [Related]
37. Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies.
Kitley J; Leite MI; Küker W; Quaghebeur G; George J; Waters P; Woodhall M; Vincent A; Palace J
JAMA Neurol; 2013 Nov; 70(11):1375-81. PubMed ID: 23999580
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and incidence of neuromyelitis optica spectrum disorder, aquaporin-4 antibody-positive NMOSD and MOG antibody-positive disease in Oxfordshire, UK.
O'Connell K; Hamilton-Shield A; Woodhall M; Messina S; Mariano R; Waters P; Ramdas S; Leite MI; Palace J
J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1126-1128. PubMed ID: 32576617
[No Abstract] [Full Text] [Related]
39. MOG encephalomyelitis: distinct clinical, MRI and CSF features in patients with longitudinal extensive transverse myelitis as first clinical presentation.
Loos J; Pfeuffer S; Pape K; Ruck T; Luessi F; Spreer A; Zipp F; Meuth SG; Bittner S
J Neurol; 2020 Jun; 267(6):1632-1642. PubMed ID: 32055995
[TBL] [Abstract][Full Text] [Related]
40. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
Kitley J; Waters P; Woodhall M; Leite MI; Murchison A; George J; Küker W; Chandratre S; Vincent A; Palace J
JAMA Neurol; 2014 Mar; 71(3):276-83. PubMed ID: 24425068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
